Inhaled iloprost improves gas exchange in patients with COVID-19 and acute respiratory distress syndrome

Inhaled iloprost improves gas exchange in patients with COVID-19 and acute respiratory distress syndrome

Bibliographic Details
Main Authors:	Natalia A. Tsareva, Sergey N. Avdeev, Djuro Kosanovic, Ralph Theo Schermuly, Natalia V. Trushenko, Galina V. Nekludova
Format:	Article
Language:	English
Published:	BMC 2021-07-01
Series:	Critical Care
Subjects:	Iloprost Inhalation SARS-CoV-2 COVID-19 Acute respiratory distress syndrome
Online Access:	https://doi.org/10.1186/s13054-021-03690-7

Similar Items

Inhaled iloprost for the treatment of pulmonary hypertension
by: H. Olschewski
Published: (2009-03-01)

Inhaled iloprost as part of combination therapy for persistent pulmonary hypertension of the newborn
by: Heru Samudro, et al.
Published: (2012-03-01)

Evaluation of compliance of pulmonary hypertension patients to the treatment with inhaled iloprost (Ventavis): results of prospective, multicenter, non-interventional IVENT study
by: Tamila V Martynyuk
Published: (2019-06-01)

Inhaled iloprost for the treatment of patient with Fontan circulation
by: Yong Hyun Kim, et al.
Published: (2014-10-01)

COVID-19 acute respiratory distress syndrome: can iloprost have a role for the treatment?
by: Alida Filippini, et al.
Published: (2021-01-01)

Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension
by: Wang L, et al.
Published: (2017-11-01)

Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study
by: Helene Haeberle, et al.
Published: (2020-03-01)

Intravenous prostacyclin analogue iloprost (Ilomedin®) in the treatment of a patient with Buerger’s disease
by: Ilshat Ravilevich Gaisin, et al.
Published: (2013-03-01)

Iloprost in COVID-19: The Rationale of Therapeutic Benefit
by: Paola Maria Faggioli, et al.
Published: (2021-04-01)

Proposal of early retreatment with iloprost in partially responsive patients with bone marrow edema syndrome: a case report
by: Simone Meini, et al.
Published: (2012-12-01)

Effect of cyclic intravenous Iloprost therapy in patients with Idiopathic Pulmonary Artery Hypertension
by: Majid MalekMohammad, et al.
Published: (2017-02-01)

Treating a Patient with Bone Marrow Edema Syndrome with Iloprost
by: mojtaba piri, et al.
Published: (2015-08-01)

Lung ultrasound can predict response to the prone position in awake non-intubated patients with COVID‑19 associated acute respiratory distress syndrome
by: Sergey N. Avdeev, et al.
Published: (2021-01-01)

Iloprost for acute tests in patients with pulmonary arterial hypertension
by: E A Belyatko, et al.
Published: (2012-12-01)

Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale
by: Djuro Kosanovic, et al.
Published: (2021-03-01)

Iloprost infusion by a new device as a portable syringe pump: safety, tolerability and agreement
by: Paola Faggioli, et al.
Published: (2012-12-01)

Hemodynamics and Gas Exchange Effects of Inhaled Nitrous Oxide in Patients with Acute Respiratory Distress Syndrome
by: V. N. Poptsov
Published: (2006-04-01)

Acute Response of Right Ventricular Function to Iloprost Inhalations in Patients with Pulmonary Arterial Hypertension: Preliminary Evaluation  with Cardiac Magnetic Resonance Imaging
by: Qingqing LU, et al.
Published: (2015-03-01)

COMPARISON OF HEMODYNAMIC EFFECTS OF INHALATORY ILOPROST AND NITRIC OXIDE IN PATIENTS WITH SEVERE LEFT VENTRICLE DYSFUNCTION
by: A. E. Bautin, et al.
Published: (2017-12-01)

Long-term clinical results after iloprost treatment for bone marrow edema and avascular necrosis
by: Tim Claßen, et al.
Published: (2016-03-01)

Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a single center
by: A. Di Vita, et al.
Published: (2012-07-01)

Iloprost Pretreatment Before Unilateral Nephrectomy: An Experimental Study in Rats
by: Erman Aytac, et al.
Published: (2008-04-01)

Acute Iloprost Inhalation Improves Right Ventricle Function in Pulmonary Artery Hypertension: A Cardiac Magnetic Resonance Study
by: Jing-Hui Li, et al.
Published: (2019-01-01)

Beneficial Effects of Iloprost on Acute Myocardial Ischemia in Dogs
by: SAKAMOTO, NOBUO, et al.
Published: (1994)

Protective effects of hyperbaric oxygen and iloprost on ischemia/reperfusion-induced lung injury in a rabbit model
by: Bozok Ş, et al.
Published: (2012-06-01)

Positive End-Expiratory Pressure and Nitric Oxide Inhalation in the Treatment of Acute Respiratory Distress Syndrome
by: V. N. Poptsov, et al.
Published: (2007-12-01)

The Effects of Iloprost on Oxygenation During One-Lung Ventilation for Lung Surgery: A Randomized Controlled Trial
by: Hoon Choi, et al.
Published: (2019-07-01)

Intravenous iloprost in the combination therapy of vascular disorders in patients with systemic connective tissue diseases
by: Aleksandr Vitalyevich Volkov, et al.
Published: (2013-06-01)

Iloprost infusion through elastomeric pump for the outpatient treatment of severe Raynaud’s phenomenon and digital ulcers – a single centre experience
by: Ana Catarina Duarte, et al.
Published: (2018-07-01)

Post-operative Unexpected Bilateral Massive Pulmonary Embolism in a Thirty-Year-Old Woman: A Case Report
by: Öznur Şen, et al.
Published: (2015-12-01)

Clinical case: combination therapy with iloprost and sildenafil in the treatment of idiopathic pulmonary hypertension
by: I N Zavyrylina, et al.
Published: (2015-06-01)

Iloprost Attenuates Oxidative Stress-Dependent Activation of Collagen Synthesis Induced by Sera from Scleroderma Patients in Human Pulmonary Microvascular Endothelial Cells
by: Roberta Giordo, et al.
Published: (2021-08-01)

Acute Respiratory Distress Syndrome (ARDS) After Nitric Acid Inhalation
by: Gülay Kır, et al.
Published: (2014-12-01)

Iloprost, a prostacyclin (PGI2) analogue, reduces liver injury in hepatic ischemiareperfusion in rats Iloprost, um análogo da prostaciclina (PGI2), reduz danos da isquemia/reperfusão hepática em ratos
by: Ercan Gedik, et al.
Published: (2009-06-01)

Inhalationally Administered Semifluorinated Alkanes (SFAs) as Drug Carriers in an Experimental Model of Acute Respiratory Distress Syndrome
by: Matthias Otto, et al.
Published: (2021-03-01)

Nitroglycerin and Iloprost Improve Mitochondrial Function in Colon Homogenate Without Altering the Barrier Integrity of Caco-2 Monolayers
by: Anna Herminghaus, et al.
Published: (2018-10-01)

Infusion of iloprost without a peristaltic pump: Safety and tolerability
by: Paola Faggioli, et al.
Published: (2013-04-01)

Co-administration of iloprost and eptifibatide in septic shock (CO-ILEPSS)—a randomised, controlled, double-blind investigator-initiated trial investigating safety and efficacy
by: Rasmus Ehrenfried Berthelsen, et al.
Published: (2019-09-01)

Role of Inhaled Nitric Oxide in the Management of Pediatric Acute Respiratory Distress Syndrome
by: Juliette Lucinda Hunt, et al.
Published: (2016-08-01)

Pulpal Response to the Combined Use of Mineral Trioxide Aggregate and Iloprost for Direct Pulp Capping
by: AlAnoud Almeshari, et al.
Published: (2021-04-01)